Site for Biomarker and Edema Attenuation in IntraCerebral hemorrhage (BEACH)

Go Back to All Clinical Trials

Site for Biomarker and Edema Attenuation in IntraCerebral hemorrhage (BEACH)

Brief description of study

Site for This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH). This study will monitor exploratory radiographic and clinical endpoints, explore the use of biochemical biomarkers to demonstrate target engagement and biological response to a potential new therapy targeted to neuroinflammation and synaptic dysfunction mechanisms.

Clinical Study Identifier: s22-00126

ClinicalTrials.gov Identifier: NCT05020535

Principal Investigator: Aaron S Lord.

Other Investigators: David E. Kahn, Laura Mary Catherine Ades, Brandon Giglio, Ting Zhou.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies